Health
STEP 4: Significant weight loss maintained with weekly semaglutide – Healio
Adults with obesity who continued once-weekly semaglutide therapy beyond 20 weeks saw continued weight loss or weight maintenance compared with adults who were…
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected] to Healio
Adults with obesity who continued once-weekly semaglutide therapy beyond 20 weeks saw continued weight loss or weight maintenance compared with adults who were switched to placebo, data from the STEP 4 study show.
“The message here is twofold. One, for the patient and the doctor, there is hope for the medical treatment of obesity,” Domenica…
Continue Reading